On this page of StockholderLetter.com we present the latest annual shareholder letter from Chemours Co — ticker symbol CC. Reading current and past CC letters to shareholders can bring important insights into the investment thesis.

 •  3/20/2025 Letter Continued (Full PDF)
 •  3/10/2023 CC Stockholder Letter
 •  4/11/2024 CC Stockholder Letter
 •  More "Specialty Chemicals" Category Stockholder Letters
 •  CC Benford's Law Stock Score = 92

CC Shareholder/Stockholder Letter Transcript:

THE CHEMOURS COMPANY
2024
ANNUAL
REPORT

DEAR CHEMOURS
STAKEHOLDERS,
DENISE M. DIGNAM
PRESIDENT & CHIEF EXECUTIVE OFFICER
It is my privilege to write to you on behalf of our leadership team to share Chemours    progress in 2024.
When l assumed the CEO role in March 2024, I understood that we were at a unique moment to step back,
take stock, and put Chemours on the best path forward to drive success and deliver shareholder value.
Where we are today is truly a reflection of how our renewed leadership team and our employees across
Chemours seized that opportunity to position the Company for value creation. I am proud to share our
accomplishments and our plans for the future.
ESTABLISHING OUR PATHWAY TO THRIVE STRATEGY
In July 2024, we added Shane Hostetter to our leadership team as our CFO. Shane has more than 20 years
of experience and demonstrated leadership capabilities. The renewed leadership team worked closely with
the Chemours Board of Directors throughout 2024 to review our entire business and listen to and learn
from our stakeholders.
In November, we introduced our Pathway to Thrive strategy that supports our work to unlock value for
shareholders and builds on our commitments to the customers and communities we serve. Pathway to
Thrive capitalizes on the fundamental strengths of our three business segments     Thermal & Specialized
Solutions, Titanium Technologies, and Advanced Performance Materials     as well as our talented people
and competitive differentiators in each segment. Under Pathway to Thrive, we have a clear framework and
actionable steps to create near- and long-term value centered around four pillars: Operational Excellence,
Enabling Growth, Portfolio Management, and Strengthening the Long Term.
PATHWAY TO THRIVE
Balanced & Disciplined Allocation To Create Shareholder Value
OPERATIONAL EXCELLENCE
ENABLING GROWTH
PORTFOLIO MANAGEMENT
Manufacturing excellence as
a basis for success
Investing smartly in selected
growth projects
Improved and standardized
operating model for
consistent execution
Commercial effectiveness to
drive sales growth
Holistic portfolio analysis
focused on distinct value
creation metrics
Continuous improvement to
adapt to changing market
>$250M cost reduction
from 2024 to 2027
Innovation and new product
development
>5% Sales CAGR from
2024 to 2027
Shift product mix to higher
value applications in growing
end markets
STRENGTHENING
THE LONG TERM
Measurable progress on
resolving legacy liabilities in
the interest of stakeholders
Responsible manufacturing
practices
Optimize asset footprint
Targeted policy efforts
Driving shareholder value
Recognizing criticality of
our chemistries

THE PILLARS OF OUR STRATEGY
We have taken significant steps to structure the organization around the four pillars of our strategy to
ensure a clear focus and emphasis on meeting shareholder expectations and delivering on our external
commitments. Our efforts to execute our strategy are well underway.
Beginning with our Operational Excellence pillar, we continue to target incremental run rate cost savings of
greater than $250 million across the Company through 2027 and remain on track to deliver half of these
run rate cost savings by the end of 2025.
In Enabling Growth, Chemours remains committed to investing in high-return, low-risk initiatives across our
portfolio while driving commercial effectiveness. We are prioritizing investments in attractive spaces with a
focus on data center cooling, next-generation refrigerants, semiconductor fabrication, and the development
of next-generation EV batteries, targeting a revenue CAGR of over 5% from 2024 through 2027.
Portfolio Management, our third strategic pillar, reflects our ongoing commitment to optimize our existing
businesses and assets by shifting our focus to applications in high-growth, higher-margin markets with
the goal of enhancing shareholder value. We will continue to closely evaluate all investments to ensure a
disciplined capital allocation approach aligned with our strategy.
Within our last pillar, Strengthening the Long Term, we remain focused on advocating for science-based
regulations for the manufacturing of our essential chemistries, applying the best science, analytical
methods, and data to support our responsible manufacturing practices, and ensuring that we make
measurable progress on addressing legacy liabilities.
We are confident that the key pillars of our Pathway to Thrive strategy will drive strong operational and
financial performance and ultimately position Chemours for long-term success and value creation.
POSITIONING FOR LONG-TERM SUCCESS
Driven by consistent and effective operational execution and a focus on unlocking productivity, we
delivered solid financial results in 2024 that demonstrate our positive momentum. For the full year 2024,
Chemours reported Net Sales of $5.8 billion and an Adjusted EBITDA of $786 million, with $148 million
returned to shareholders through cash dividends. Each business segment drove key priorities in line with
our Pathway to Thrive strategy.
Thermal & Specialized Solutions (TSS) continued transitioning into low global warming potential (GWP)
Opteon    Refrigerants, including a 40% capacity expansion at our Corpus Christi site in Texas of which half
will become available in 2025. This additional capacity is essential to meet the strong customer demand
for Opteon    as regulatory-driven low GWP adoption continues to accelerate in 2025. Our 2024 results
reflected this continued transition to low GWP refrigerants with Opteon    delivering 14% sales growth
versus 2023, which we believe will continue to support 30% margins as we head into 2025.
Titanium Technologies (TT) remained focused on driving solid commercial performance and continued
to make strong progress against its Transformation Plan, outperforming expectations by achieving
approximately $140 million of total cost savings in 2024. We delivered stable volumes, despite the historic
drought that temporarily impacted our Altamira site and continued slower-than-expected market recovery.
Even with the challenges faced during the year, our focus on cost reduction provided for year-over-year
margin improvement.
Advanced Performance Materials (APM) benefited from our capacity expansion for Teflon    PFA resin
production, a critical material for semiconductor manufacturing. This was a key priority for the APM
leadership team and represents an important step forward in meeting PFA demand and serving our
customers in the semiconductor market. We also continue to make strides in APM around optimizing our
portfolio and ensuring that we have an underlying asset base generating strong returns.

At the corporate level, in partnership with our Board, we fully remediated our four material weaknesses in
internal control, which were identified in connection with the Audit Committee   s internal review in early 2024.
The swift remediation of these material weaknesses was a critical priority for the entire leadership team.
The completion of this work is symbolic of the final step needed to move past the events of the prior year.
ADVANCING A WINNING CULTURE
Our values are the foundation of our culture and guide the daily actions and decisions of our people as we
execute our Pathway to Thrive strategy. In 2024, we refreshed our values through extensive conversations
and direct input from thousands of Chemours team members, ensuring that the values are plain spoken,
memorable, and directly connected to our everyday work and business performance.

Safety: We are committed to protecting people and the environment.

Integrity: We do what   s right.

Partnership: We win through collaboration with the right internal and external partners.

Ownership: We are each accountable for the Company   s success.

Respect: We treat people well, include others, and value diverse perspectives.
Ultimately, it is our people that make us who we are, and our values embody a Chemours culture that allows
every team member to thrive and drives our strategy. In our values and in our operations, we put safety
first and work to ensure that every team member returns home to their families safely at the end of each
day. We are proud to provide meaningful opportunities and support for employees at all levels and from
all backgrounds, fostering both personal and professional growth through investing in their development,
health, and wellbeing. Without the safety and wellbeing of our team, nothing else matters.
LOOKING AHEAD
I want to thank our dedicated global team of 6,000 employees for the tremendous work they did in 2024.
Their resilience, commitment to our customers, and ability to execute are reflected in our results and the
progress we made, and I look at our team   s achievements with great pride.
We have set ambitious goals and there is more work to do, but we are confident in our plan and the future
for Chemours. We have great businesses, best-in-industry talent, a refreshed corporate strategy, and a
strong foundation to take Chemours forward.
Our 2025 priorities are clear. Our Board, leadership team, and teams across our operations are united
in our commitment to execute our strategy and continue our progress to drive enhanced value creation
for shareholders.
Thank you for your continued support.
Sincerely,
Denise Dignam
President & Chief Executive Officer



 3/20/2025 Letter Continued (Full PDF)